Amparo Vayá

Amparo Vayá

Auto-generated profile, based on publicly available information

Amparo Vayá

Hemorheology and Haemostasis Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2002 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
AVAmparo Vayá
Amparo Vayá
YMYolanda Mira
Yolanda Mira
FFFernando Ferrando
Fernando Ferrando
MCMaTeresa Contreras
MaTeresa Contreras
AEAmparo Estelles
Amparo Estelles
JAJusto Aznar
Justo Aznar
Summary. To ascertain the potential contribution of serum lipids to the development of deep vein thrombosis (DVT), a case–control study was conducted in 143 DVT patients lacking thrombophilic risk factors and in 194 age‐ and sex‐matched controls. DVT patients showed significantly higher body mass indices (BMI), and triglyceride levels than did controls (P < 0·001 and P = 0·045 respectively). Using multivariate analysis, BMI was the only variable which remained statistically different, thus the risk of DVT was associated with obesity (odds ratio = 2·49). These results were confirmed when additional control for fibrinogen and plasminogen activator inhibitor type 1 (PAI‐1) was carried out in a subgroup of cases and controls. When idiopathic (n = 39) and secondary (n = 104) patients with DVT were compared, the former showed a higher mean age, a higher proportion of men, and higher cholesterol levels. Age, sex and total cholesterol were statistically different by multivariate analysis. After age was dichotomized as ≥ 50 years and cholesterol ≥ 5·69 mmol/l, all three variables constituted independent risk factors for idiopathic DVT, with odds ratios of 2·73 for ages ≥ 50 years; 3·72 for men and 2·67 for cholesterolaemia ≥ 5·69 mmol/l. Obesity thus constitutes an independent risk factor for DVT, possibly in part mediated through triglyceride, fibrinogen and PAI‐1 effects on haemostasis. In addition, cholesterolaemia levels of ≥ 5·69 mmol/l constitute an independent risk factor for idiopathic DVT.

1 January 2006 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
JRJosé M Ricart
José M Ricart
JTJosé Todolí
José Todolí
JCJavier Calvo
Javier Calvo
PVPiedad Villa
Piedad Villa
AEAmparo Estellés
Amparo Estellés
AVAmparo Vayá
Amparo Vayá
Behçet’s disease (BD) is a chronic inflammatory disorder in which thrombosis occurs in about 30% of patients. The prothrombotic mechanisms are unknown. Thrombophilic defects and hyperhomocysteinaemia may be involved in the pathogenesis of thrombotic events, although results have been controversial. Moreover, no information is available on this issue for eastern Spain.We studied the prevalence of inherited and acquired thrombophilic risk factors in 79 patients with BD (43 men, 36 women) who had (n = 23) or did not have (n = 56) thrombosis, and in 84 healthy control subjects (42 men, 42 women). Risk factors examined were antithrombin, protein C and protein S levels, factor V Leiden, the prothrombin G20210A mutation, the methylenetetrahydrofolate reductase C677T polymorphism, and acquired thrombophilic risk factors, including anticardiolipin antibodies, lupus anticoagulant, and serum homocysteine levels. There were no differences between patients and controls in any of the parameters studied.When we studied BD patients with and without thrombotic events, the only thrombophilic defect that differed was the prothrombin G20210A mutation: Three out of 23 patients with thrombosis were carriers, compared with none of 56 patients without thrombosis (p = 0.022).Two of the three carriers developed catastrophic or recurrent thrombotic episodes; one wasa homozygous carrier of the G20210A prothrombin mutation and the other was doubly heterozygous for the G20210A prothrombin mutation and factor V Leiden. A meta-analysis demonstrated an association of factor V Leiden and prothrombin mutation with thrombosis in BD. When studies from Turkey were excluded from the meta-analysis, only the prothrombin G20210A mutation was associated with thrombosis.

1 January 2013 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
AVAmparo Vayá
Amparo Vayá
RARafael Alis
Rafael Alis
JHJose-Luis Hernández
Jose-Luis Hernández
JCJavier Calvo
Javier Calvo
LMLuisa Micó
Luisa Micó
JRJose M. Ricart
Jose M. Ricart
Red blood cell distribution width (RDW) is a routine parameter that reflects size variations in erythrocytes. High RDW has been associated with cardiovascular events and inflammatory diseases. However, no studies evaluating the association of RDW with systemic lupus erythematosus (SLE) have been published. We aimed to explore the association of RDW with inflammatory markers in SLE. As SLE is often associated with anaemia, we considered this factor in order to know whether RDW is related with inflammation, anaemia or both in SLE. The study included 105 SLE patients (7 men, 98 women; aged 15–73 years) and 105 controls (9 men, 96 women; aged 18–71 years). Patients were divided according to anaemia status (26 with, 79 without). Biochemical, hematological and inflammatory parameters (C-reactive protein (CRP), fibrinogen and erythrocyte aggregation (EA1)) were analyzed. SLE patients showed increased RDW, CRP and EA1 (p < 0.001), and decreased hemoglobin levels (p < 0.001) when compared with controls. RDW was higher in SLE patients with anaemia (a-SLE) as compared with those without anaemia (na-SLE) (p < 0.01) or controls (p < 0.001). CRP in a-SLE was higher than in controls (p < 0.01) but lower than in na-SLE (p < 0.05). In na-SLE RDW correlated directly with fibrinogen and CRP (p < 0.001), but not in a-SLE. Our results indicate that SLE patients show higher RDW irrespectively of anaemia status, and that RDW is influenced by both anaemia and inflammation, but the influence of anaemia is stronger.

1 January 2013 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
AVAmparo Vayá
Amparo Vayá
MSMarta Suescun
Marta Suescun
The role played by hemorheological alterations in the development of deep vein thrombosis (DVT) has often been overlooked. Although marked rheological alterations and the relationship with thromboembolic events are well-defined in patients with hematological diseases such as myelom, Waldenström disease and polycythemia vera, the relationship is not so clear in patients without hematological diseases. In the present review, we analyzed studies evaluating the rheological profile in DVT patients. Among the cardiovascular risk factors, only hyperlipidemia, metabolic syndrome, tobacco and obesity increase DVT risk and, in addition, a disturbed rheological profile is shown which could further increase this risk. The significance of hematocrit and fibrinogen, the main factors influencing blood viscosity, is not sufficient to increase blood viscosity in any of the studies analyzed. DVT patients show increased fibrinogen levels and erythrocyte aggregation throughout all the studies despite patients not being in an acute reactant phase. In addition to rheological alterations, it is necessary to consider local conditions at pockets of venous valves which undergo deterioration with aging and play an important role equally to alterations in the rheological profile. Moreover, it is necessary to take into account that systemic rheological alterations are not comparable to those in low shear rate areas where minimum disturbances could be more relevant. It would be convenient to perform multicentric studies with the same rheological methodology and pre-analytical procedures to evaluate, in order to obviate the effect of thrombophilic and circumstantial risk factors, rheological parameters in patients with spontaneous DVT to elucidate their real contribution to the development of thromboembolic events.

1 June 2011 in Metabolic Syndrome and Related Disorders
Verified
Journal Article
Closed access
AVAmparo Vayá
Amparo Vayá
MMMaría L. Martínez-Triguero
María L. Martínez-Triguero
FEFrancisco España
Francisco España
JTJosé A. Todolí
José A. Todolí
EBElena Bonet
Elena Bonet
DCDolores Corella
Dolores Corella
Introduction: The association of metabolic syndrome with venous thromboembolism (VTE) remains uncertain. Moreover, the relevance of abdominal obesity as an independent or related risk factor for VTE in the metabolic syndrome cluster is controversial. We aimed to evaluate the impact of metabolic syndrome and its individual components on VTE risk. Methods: We conducted a case–control study to investigate the presence of metaoblic syndrome in 150 healthy individuals (43 ± 13 years) and 146 patients with a first objectively confirmed episode of deep venous thrombosis or pulmonary embolism (44 ± 13 years) who underwent a thrombophilia work up. Results: Metabolic syndrome was present in 19% of cases and 8% of controls (P = 0.008). In the unadjusted analysis, metabolic syndrome was statistically associated with higher VTE risk [odds ratio (OR) = 2.7, 95% confidence interval (CI) 1.3–5.6]. However, hypertriglyceridemia (OR = 2.0, 95% CI 1.1–3.5), high glucose levels (OR = 2.0, 95% CI 1.2–3.5), and abdominal obesity (OR = 5.7, 95% CI 3.4–9.6) were also significantly associated with higher VTE risk. Abdominal obesity was the factor that had the highest OR. Moreover, after multivariate analysis in which each independent factor was adjusted for the others, only abdominal obesity remained statistically associated with higher VTE risk, revealing its relevance. Further adjustment for the presence of thrombophilia did not change the estimation. Conclusion: We conclude that, in subjects with a mean age of 44 years, metabolic syndrome increases VTE risk, although abdominal obesity is the pivotal factor.

1 January 2015 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
PDF file
AVAmparo Vayá
Amparo Vayá
LRLeonor Rivera
Leonor Rivera
RERafael de la Espriella
Rafael de la Espriella
FSFernando Sanchez
Fernando Sanchez
MSMarta Suescun
Marta Suescun
LFLorenzo Fácila
Lorenzo Fácila
Increased RDW has been found to be a marker of adverse outcomes in cardiovascular disease (CVD), although the exact mechanism remains unclear. Recently, several authors have found that higher RDW is associated with decreased erythrocyte deformability, which can impair blood flow through microcirculation, a fact which may explain the increased risk for CVD events associated with elevated RDW. The aim of the present study was to investigate the association between RDW and erythrocyte deformability in patients with acute myocardial infarction (AMI). The study group comprised 60 AMI patients and 72 gender- and age-matched controls, in whom erythrocyte deformability was determined by means of the elongation index (EI) in a Rheodyn SSD, along with haematological, biochemical and inflammatory parameters. Patients showed higher RDW (p = 0.012) and lower EI (p < 0.05) than controls. When anaemic patients were removed from the study, AMI showed still lower EI than controls (p < 0.05), but no differences in RDW were observed (p = 0.141). RDW correlated inversely with haematimetric indices (p < 0.001), but not with inflammatory and biochemical parameters (p > 0.05). EI correlated inversely with Hb, MCHC (p < 0.001) and directly with MCV (p < 0.05). EI also correlated inversely with glucose (p < 0.05) and directly with HDL-cholesterol (p < 0.05). The multivariate regression model showed that only MCV and Hb were independent predictors of RDW (beta coefficients: −0.383, −0.208; p < 0.001, p = 0.050, respectively). In addition, MCV, MCHC and hyperlipidaemia were independent predictors of EI (beta coefficients: 0.366, −0.533, −0.192; p < 0.001, p < 0.001, p = 0.019 respectively). In AMI patients, increased RDW is not related with EI, so this mechanism does not seem to be responsible for an increased CDV risk in these patients.